Fluarix

Fluarix

(floo′ă-rĭks)
Influenza virus vaccine, trivalent, types A and B.
References in periodicals archive ?
M2 EQUITYBITES-February 19, 2018-GSK receives European approval for expanded indication for Fluarix Tetra
M2 PHARMA-February 19, 2018-GSK receives European approval for expanded indication for Fluarix Tetra
5 mL) Inactivated influenza vaccine, quadrivalent (IIV4), standard dose Fluarix GlaxoSmithKline 0.
html), which includes the Fluarix and FluLaval vaccines.
Four new, recently licensed vaccines are now available: FluMist Quadrivalent nasal LAIV (LAIV4) from Medlmmune for persons aged 2-49 years; Fluarix Quadrivalent inactivated influenza vaccine (IIV4) from GlaxoSmithKline for those 3 years and older; Flucelvax, a cell culture-based inactivated influenza vaccine (ccIIV3) from Novartis for patients aged 18 years and older; and Flublok, a recombinant hemagglutinin vaccine from Protein Sciences for adults aged 18-49 years.
Four-strain versions are sold under the names Fluzone Quadrivalent, Fluarix Quadrivalent and FluLaval Quadrivalent.
1) Also, studies done by the Food and Drug Administration (FDA) prior to release of the Fluarix vaccine, as reported in the Physician's Desk Reference (PDR), show that 49.
GlaxoSmithKline will manufacture both the trivalent and quadrivalent forms of Fluarix for next season, a company representative said.
Currently, trivalent intramuscular vaccines such as Sanofi's Fluzone and Vaxigrip, GlaxoSmithKline's Fluarix and FluLaval and Novartis' Fluvirin garner the majority stake of the market.
GSK also believes distribution of its Fluarix, another influenza vaccine, will follow in the next few weeks.